Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Manufacturing
Pharma
FTC to review Novo Holdings' Catalent buyout for another month
Despite a new 30-day extension on the FTC's review of Novo Holdings' Catalent buyout, the CDMO giant still expects the deal to close by year-end 2024.
Fraiser Kansteiner
May 3, 2024 2:00pm
Merck's BCG monopoly could end
May 3, 2024 10:50am
Emergent to cut 300 jobs, shutter 2 facilities in major overhaul
May 1, 2024 5:06pm
WuXi Bio pulls out of 2024 BIO convention
May 1, 2024 2:48pm
BIO survey to elucidate US biopharma's reliance on Chinese CDMOs
May 1, 2024 11:00am
Lilly: Zepbound, Mounjaro supply to remain tight through 2024
Apr 30, 2024 12:03pm